Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29e307166bd42ff218bcceb8e166d0fa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
filingDate |
2019-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87b731cf89f95d0a31c78a2397f1bc83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93a14bf8ebf246c31004694b77191c72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8abe17fe94e0eab3e7d83dd6e54dcc84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46321c73d94c5e8923daf5248d8e0bca |
publicationDate |
2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2020098969-A1 |
titleOfInvention |
Improved dosage regimen for ursodeoxycholic acid based on alkaline phosphatase levels in the treatment of chronic cholestatic liver diseases |
abstract |
The present invention relates to the treatment of chronic cholestatic liver diseases with ursodeoxycholic acid (UDCA) with an improved dosage regimen. |
priorityDate |
2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |